5 drug(s) with this reaction
17,672 total reports
Drug Dose Omission has been reported as an adverse reaction across 5 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 17,672 adverse event reports mention drug dose omission in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with drug dose omission, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have drug dose omission listed in their FDA adverse event reports, sorted by report count:
In addition to drug dose omission, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
5 drug(s) manufactured by Abbvie Inc have drug dose omission listed in their FDA adverse event reports: Humira, ADALIMUMAB, DIVALPROEX SODIUM, FENOFIBRATE, GLECAPREVIR AND PIBRENTASVIR.
There are a combined 17,672 reports of drug dose omission across 5 Abbvie Inc drug(s) in the FDA adverse event database.